In 2024, Asker Healthcare Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Asker Healthcare Group has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021-2019 |
|---|---|---|---|---|
Total Scope 1 | 4,343a | 4,571a | N/A | |
Total Scope 2 | ||||
Market-Based | 978a | 1,143a | N/A | |
Location-Based | 2,830a | 2,927a | N/A | |
Total Scope 3 | 544,038a | 474,218a | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 3.1853a | 3.4279a | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, the total operational greenhouse gas (GHG) emissions of Asker Healthcare Group amounted to 7,173 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Asker Healthcare Group decreased by 4.33%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2024, the total Scope 1 emissions of Asker Healthcare Group were 4,343 metric tons of CO₂ equivalent (tCO₂e).a
Since 2021, Asker Healthcare Group's Scope 1 emissions have decreased by 16.58%, reflecting a declining long-term trend in Scope 1 emissions over time.a
Compared to the previous year (2023), Asker Healthcare Group's Scope 1 emissions decreased by 4.99%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2024, Asker Healthcare Group reported Scope 2 greenhouse gas (GHG) emissions of 978 tCO₂e using the market-based method and 2,830 tCO₂e using the location-based method.a
Since 2021, Asker Healthcare Group's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 10.42%, reflecting a rising long-term trend in Scope 2 emissions over time.a
Compared to the previous year (2023), Asker Healthcare Group's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Asker Healthcare Group's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2024, Asker Healthcare Group reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2024, Asker Healthcare Group reported 544,038 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Asker Healthcare Group includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2024, Asker Healthcare Group reported total Scope 3 emissions of 544,038 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 97.33% of these emissions originated from upstream activities such as purchased goods and capital goods, while 2.67% came from downstream activities like product use, distribution, and end-of-life treatment.a
Since 2021, Asker Healthcare Group's Scope 3 emissions have increased by 37.51%, reflecting a rising long-term trend in Scope 3 emissions over time.a
Compared to the previous year (2023), Asker Healthcare Group's Scope 3 emissions increased by 14.72%, suggesting that the company faced challenges in reducing emissions across its value chain.a
In 2024, Asker Healthcare Group reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2024, the largest contributors to Asker Healthcare Group's Scope 3 emissions were:a
In 2024, Asker Healthcare Group reported Scope 1 greenhouse gas (GHG) emissions of 4,343 tCO₂e and total revenues of USD 1,363 millions. This translates into an emissions intensity of 3.19 tCO₂e per millions USD.a
In 2024, Asker Healthcare Group reported a Scope 1 emissions intensity of 3.19 tCO₂e per millions USD. Compared to the peer group median of 1.51, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2024, Asker Healthcare Group ranked 19 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Asker Healthcare Group among the least efficient performers, with one of the highest emissions intensities in its sector.a
In 2024, Asker Healthcare Group reported a total carbon footprint of 551,211 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 14.43% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Asker Healthcare Group's total carbon footprint was Scope 3 emissions, accounting for 98.7% of the company's total carbon footprint, followed by Scope 1 emissions at 0.79%.a